NCT06339437

Brief Summary

this study will be conducted involving patients of all genders between the ages of 20 and 60 years who will undergo elective laparoscopic cholecystectomy for uncomplicated symptomatic gallstone disease. The study will be conducted in Department of West Surgical Ward, Mayo Hospital, Lahore, after receiving approval from the hospital's Ethical Committee. Patients having other co-morbid conditions, pregnant patients, and those undergoing laparoscopic cholecystectomy converted to open surgery will be excluded from the study. LFTs and other baseline investigations will be done routinely of every patient. Written informed consent will be obtained from all the patient. Patients will be divided into two groups with 30 patients in each group. Group A will consist of patient in whom ERAS protocol will be implemented and Group B in whom ERAS protocol will not be implemented.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 25, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 1, 2024

Completed
Last Updated

April 12, 2024

Status Verified

April 1, 2024

Enrollment Period

7 months

First QC Date

March 25, 2024

Last Update Submit

April 11, 2024

Conditions

Keywords

ERASGALL STONE DISEASELAPAROSCOPIC CHOLECYSTECTOMY

Outcome Measures

Primary Outcomes (2)

  • PONV

    post op nausea and vomiting measured

    24 hours

  • Visual Analogue Scale score

    pain assessed by visual analogue scale and higher score means worse outcome and less score means better outcome

    24 hours

Study Arms (2)

ERAS group

EXPERIMENTAL

ERAS protocol applied in this group

Other: ERAS Protocol

non ERAS group

NO INTERVENTION

conventional method of post op care was used

Interventions

Ehanced recovery after surgery protocols were applied

ERAS group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Ages between 20 to 60 years
  • All genders included
  • ASA class I and II
  • Undergoing elective laparoscopic cholecystectomy for uncomplicated symptomatic gallstone disease.

You may not qualify if:

  • Patients having other co-morbid conditions like uncontrolled diabetes (BSR\>300) and uncontrolled hypertension (Blood Pressure\>180/110).
  • Previous abdominal surgery documented previous medical records.
  • Pregnant patients documented on history
  • Those undergoing laparoscopic cholecystectomy converted to open surgery proved by per-operative findings
  • Immunocompromised patients documented on previous medical records.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Children Hospital

Lahore, Punjab Province, 42000, Pakistan

Location

MeSH Terms

Conditions

Cholelithiasis

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System Diseases

Study Officials

  • Adeel A Gujjar, M.S

    Consultant Surgeon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
outcomeassessor was not told about group allocation
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: ERAS protocols applied
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 25, 2024

First Posted

April 1, 2024

Study Start

April 1, 2023

Primary Completion

October 30, 2023

Study Completion

November 1, 2023

Last Updated

April 12, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

not sharing

Locations